Masato Asahiyama

Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content

Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka et al. · Scientific Reports · 2020 · 110 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Preparation and properties of carrageenan microspheres containing allopurinol and local anesthetic agents for the treatment of oral mucositis

Keishiro Tomoda, Masato Asahiyama, Takehisa Nakajima et al. · Colloids and Surfaces B Biointerfaces · 2009 · 34 citations

Pharmacy, Oral Medicine, Periodontics +14

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis

Kentaro Murakami, Yusuke Sasaki, Masato Asahiyama et al. · Cells · 2022 · 34 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Collaborative work on evaluation of ovarian toxicity 9) Effects of 2- or 4-week repeated dose studies and fertility study of di(2-ethylhexyl)adipate (DEHA) in female rats

Eiji Wato, Masato Asahiyama, Suzuki Ai et al. · The Journal of Toxicological Sciences · 2009 · 23 citations · Full text

Pharmacy, Pharmacology, Toxicology +17